Search documents
B. Riley Financial(RILY) - 2025 Q4 - Annual Report
2026-03-31 20:13
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________________________ FORM 10-K _____________________________________ (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 Or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-37503 _________________________________ ...
B RLY FINCL(RILYP) - 2025 Q4 - Annual Report
2026-03-31 20:13
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________________________ FORM 10-K _____________________________________ (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 Or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-37503 _________________________________ ...
Ryerson Announces Leadership Team Changes to Accelerate Strategic Integration of the Newly Merged Organization
Prnewswire· 2026-03-31 20:13
Ryerson Announces Leadership Team Changes to Accelerate Strategic Integration of the Newly Merged Organization Accessibility StatementSkip Navigation Richard Manson, Sr. Vice President – Finance (Ryerson) / Chief Financial Officer – Olympic SteelMr. Manson will lead synergy attainment for the newly merged Company, along with the integration of benefits programs and compensation. He will assume leadership for Ryerson's Corporate Finance Planning & Analysis department and continue to serve as Chief Financ ...
Volition(VNRX) - 2025 Q4 - Annual Results
2026-03-31 20:12
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 31, 2026 VolitionRx Limited (Exact name of registrant as specified in its charter) (State or other jurisdiction (Commission File Number) (IRS Employer Delaware 001-36833 91-1949078 (Address of principal executive offices and Zip Code) +1 (512) 774-8930 (Registrant's telephone number, incl ...
The Market Is Giving You A Gift, Don't Overthink It



Seeking Alpha· 2026-03-31 20:12
It has been a little over a month since I wrote the article “Not A Bear Market Yet, But It’s Already A Stock Picker’s Dream.” My opinion on the market in general was simple: the main indexes hadEquity Research Analyst with a broad career in the financial market, covered both Brazilian and global stocks. As a value investor, my analysis is primarily fundamental, focusing on identifying undervalued stocks with growth potential. Feel free to reach out for collaborations or to connect!Analyst’s Disclosure: I/we ...
Ynvisible Announces Closing of Second Tranche of Non-Brokered Private Placement
TMX Newsfile· 2026-03-31 20:12
Vancouver, British Columbia--(Newsfile Corp. - March 31, 2026) - Ynvisible Interactive Inc. (TSXV: YNV) (FSE: 1XNA) (the "Company" or "Ynvisible") announces that further to its news releases of March 13 and March 26, 2026, the Company has now closed a second tranche ("Second Tranche") of its non-brokered private placement (the "Private Placement") of up to 20,000,000 units ("Units"). In the Second Tranche, the Company issued 3,169,000 Units at a price of $0.10 per Unit for total gross proceeds of $316,900. ...
NEXGEL Reschedules 2025 Financial Results Conference Call to April 8th at 4:30 P.M. ET to Provide Shareholders with an Update on Its Previously Announced Transaction with Celularity
Globenewswire· 2026-03-31 20:12
LANGHORNE, Pa., March 31, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced the rescheduling of its fourth quarter and fiscal year 2025 financial results conference call to April 8, 2026 at 4:30 P.M. ET to provide additional time for the Company to provide shareholders with greate ...
Rayonier Maintains Current Name and Ticker Symbol, Introduces New Logo
Businesswire· 2026-03-31 20:12
Rayonier Maintains Current Name and Ticker Symbol, Introduces New Logo Mar 31, 2026 4:12 PM Eastern Daylight Time Rayonier Maintains Current Name and Ticker Symbol, Introduces New Logo Share Rayonier's common stock will continue to trade on the New York Stock Exchange under the ticker symbol "RYN†. About Rayonier Rayonier is a land resources real estate investment trust (REIT) with a portfolio comprising over four million acres in the U.S. South and U.S. Northwest. The company is focused on managing its t ...
J.Jill(JILL) - 2026 Q4 - Annual Report
2026-03-31 20:11
FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended January 31, 2026 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 001-38026 J.Jill, Inc. (Exact name of Registrant as specified in its Charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Delaware 45-1459825 (State or other jurisdiction of incorp ...
Athira Pharma(ATHA) - 2025 Q4 - Annual Report
2026-03-31 20:11
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 LeonaBio, Inc. For the fiscal year ended December 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-39503 (Exact name of registrant as specified in its charter) | Delaware | 45-3368487 | | --- | --- | | (State or other ...